Cargando…
The role of roxadustat in chronic kidney disease patients complicated with anemia
The incidence of chronic kidney disease (CKD) is increasing worldwide and the current prevalence rate is 13.4%. There are > 120 million CKD patients in China and this number is expected to increase. One of the main abnormalities in patients with CKD and kidney impairment is decreased synthesis of...
Autores principales: | Liu, Jie, Yang, Fan, Waheed, Yousuf, Li, Shulin, Liu, Kun, Zhou, Xinglei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Internal Medicine
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993099/ https://www.ncbi.nlm.nih.gov/pubmed/36588451 http://dx.doi.org/10.3904/kjim.2022.318 |
Ejemplares similares
-
Iron Parameters in Patients Treated with Roxadustat for Anemia of Chronic Kidney Disease
por: Ganz, Tomas, et al.
Publicado: (2023) -
Roxadustat for the treatment of anemia in patients with chronic kidney diseases: a meta-analysis
por: Zhang, Li, et al.
Publicado: (2021) -
Whether Prolyl Hydroxylase Blocker—Roxadustat—In the Treatment of Anemia in Patients with Chronic Kidney Disease Is the Future?
por: Grzeszczak, Władysław, et al.
Publicado: (2021) -
Efficacy and Mechanism of Roxadustat plus Oral Iron in the Treatment of Elderly Chronic Kidney Disease with Anemia
por: Liu, Bo, et al.
Publicado: (2022) -
Roxadustat: Not just for anemia
por: Zhu, Xiaoyu, et al.
Publicado: (2022)